1. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients
- Author
-
M. Fischer, Mathias Hofer, Andreas Dietz, Christian Mozet, Marlen Kolb, Cindy Herchenhahn, Andreas Boehm, and Gunnar Wichmann
- Subjects
Adult ,Male ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Human leukocyte antigen ,Disease-Free Survival ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,HLA Antigens ,Risk Factors ,Internal medicine ,Epidemiology of cancer ,Genetic predisposition ,Humans ,Medicine ,Progression-free survival ,neoplasms ,Alleles ,Aged ,Squamous Cell Carcinoma of Head and Neck ,business.industry ,Proportional hazards model ,Genetic heterogeneity ,Middle Aged ,medicine.disease ,Head and neck squamous-cell carcinoma ,stomatognathic diseases ,030104 developmental biology ,Haplotypes ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Female ,Oral Surgery ,business - Abstract
Personalized medicine and treatment stratification of patients with head and neck squamous cell carcinoma (HNSCC) today mostly ignore genetic heterogeneity in HNSCC but especially the patient's genetic background. We hypothesized that particular human leukocyte antigen (HLA) class I (HLA-A, B, Cw) and II proteins (DR, DQ) confer susceptibility for and influence development of HNSCC and may be prognostic factors for progression-free survival (PFS).90 consecutive HNSCC patients of the prospective observational cohort study LIFE treated between 08/2010 and 05/2011 at the University Leipzig underwent low resolution typing of HLA-A, B, Cw, DR, and DQ. Antigen and haplotype frequencies were compared to those in German blood donors. Effects on PFS were analyzed using Kaplan-Meier curves and Cox models.HNSCC patients had overall altered HLA-B frequencies (P0.05); frequencies of B∗44 were lower, those of B∗13, B∗52, and B∗57 increased (P0.05). Almost all other antigen frequencies showed no deviation. Homozygous HLA-Cw and DRB4 were frequent and associated with reduced PFS (P0.05). Altered haplotype frequencies were common and particular haplotypes accompanied by differing PFS. B∗13/Cw∗06 carriers had poorest outcome (P=0.011). However, multivariate Cox proportional hazard models revealed 3 clinical covariates (localization oropharynx, loco-regional metastasis, and T4 category), HPV16-DNA positivity, and 10 HLA traits as independent predictors for PFS.The relevance of the genetic background of HNSCC patients calls for future research to clarify the role of HLA traits in HNSCC and if PFS depends on HLA.
- Published
- 2017